BioCentury
ARTICLE | Company News

FDA panel wants more AlzheimAlert data

July 19, 2005 12:50 AM UTC

Nymox (NYMX) said that on Friday an FDA panel voted 5-2 against approval of a kit version of AlzheimAlert to diagnose Alzheimer's disease (AD). NYMX said the panel felt more data was needed, including...